[go: up one dir, main page]

AU2001278011A1 - Bstp-ecg1 protein and related reagents and methods of use thereof - Google Patents

Bstp-ecg1 protein and related reagents and methods of use thereof

Info

Publication number
AU2001278011A1
AU2001278011A1 AU2001278011A AU7801101A AU2001278011A1 AU 2001278011 A1 AU2001278011 A1 AU 2001278011A1 AU 2001278011 A AU2001278011 A AU 2001278011A AU 7801101 A AU7801101 A AU 7801101A AU 2001278011 A1 AU2001278011 A1 AU 2001278011A1
Authority
AU
Australia
Prior art keywords
ecg1
bstp
protein
methods
related reagents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001278011A
Other languages
English (en)
Inventor
David Botstein
Patrick O Brown
Chuck Perou
Douglas Ross
Rob Seitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Genomics Inc
Leland Stanford Junior University
Original Assignee
Applied Genomics Inc
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Genomics Inc, Leland Stanford Junior University filed Critical Applied Genomics Inc
Publication of AU2001278011A1 publication Critical patent/AU2001278011A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001278011A 2000-07-26 2001-07-26 Bstp-ecg1 protein and related reagents and methods of use thereof Abandoned AU2001278011A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22096700P 2000-07-26 2000-07-26
US60/220,967 2000-07-26
US25166900P 2000-12-06 2000-12-06
US60/251,669 2000-12-06
PCT/US2001/023439 WO2002008260A2 (fr) 2000-07-26 2001-07-26 Proteine bstp-ecg1 et reactifs associes et procedes d'utilisation de ceux-ci

Publications (1)

Publication Number Publication Date
AU2001278011A1 true AU2001278011A1 (en) 2002-02-05

Family

ID=26915369

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001278011A Abandoned AU2001278011A1 (en) 2000-07-26 2001-07-26 Bstp-ecg1 protein and related reagents and methods of use thereof

Country Status (2)

Country Link
AU (1) AU2001278011A1 (fr)
WO (1) WO2002008260A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2799555B1 (fr) 2002-03-13 2017-02-22 Genomic Health, Inc. Profilage de l'expression génétique dans des tissus de tumeurs prélevées par biopsie
WO2004046386A1 (fr) 2002-11-15 2004-06-03 Genomic Health, Inc. Etablissement de profils d'expressions genetique du cancer a recepteur de facteur de croissance epidermique positif
US20040231909A1 (en) 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure
WO2004074518A1 (fr) 2003-02-20 2004-09-02 Genomic Health, Inc. Utilisation d'arn intronique pour mesurer l'expression genique
US20040185559A1 (en) 2003-03-21 2004-09-23 Isis Pharmaceuticals Inc. Modulation of diacylglycerol acyltransferase 1 expression
EP3470535B1 (fr) 2003-06-24 2020-04-01 Genomic Health, Inc. Prédiction de probabilité de récurrence de cancer
EP3330875B1 (fr) 2003-07-10 2021-12-01 Genomic Health, Inc. Algorithme de profil d'expression et de test pour le pronostic de la recurrence du cancer du sein
US7825235B2 (en) 2003-08-18 2010-11-02 Isis Pharmaceuticals, Inc. Modulation of diacylglycerol acyltransferase 2 expression
ES2360113T3 (es) 2003-12-23 2011-06-01 Genomic Health, Inc. Amplificación universal de rna fragmentado.
EP2163650B1 (fr) 2004-04-09 2015-08-05 Genomic Health, Inc. Marqueurs d'expression de gènes pour prédire une réponse à la chimiothérapie
US7587279B2 (en) 2004-07-06 2009-09-08 Genomic Health Method for quantitative PCR data analysis system (QDAS)
CA2585561C (fr) 2004-11-05 2018-07-17 Genomic Health, Inc. Resultat de groupe esr1, pgr, bcl2 et scube2 comme indicateurs de pronostic de cancer du sein et de prediction de la reponse au traitement
ES2778851T3 (es) 2004-11-05 2020-08-12 Genomic Health Inc Predicción de la respuesta a la quimioterapia mediante el uso de marcadores de expresión génica
WO2007128120A1 (fr) 2006-05-08 2007-11-15 Canimex Inc. Dispositif de freinage avec mécanisme antivol intégré pour portes de garage et similaires et ensemble de porte incluant le dispositif
ES2397661T3 (es) 2006-08-04 2013-03-08 Isis Pharmaceuticals, Inc. Composiciones y sus usos dirigidos a la diacilglicerol aciltransferasa 1
WO2017011276A1 (fr) 2015-07-10 2017-01-19 Ionis Pharmaceuticals, Inc. Modulateurs de diacylglycérol acyltransférase 2 (dgat2)
CN110489660B (zh) * 2019-07-22 2020-12-18 武汉大学 一种社交媒体公开数据的用户经济状况画像方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69932607T2 (de) * 1998-02-25 2007-10-25 The United States Government As Represented By The Department Human Services Verfahren und vorrichtung zur erstellung eines arrays für schnelle molekulare profilidentifizierungen
DE19813835A1 (de) * 1998-03-20 1999-09-23 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Brustnormalgewebe
CA2339043A1 (fr) * 1998-09-01 2000-03-09 Genentech, Inc. Nouveaux pro-polypeptides et sequences correspondantes

Also Published As

Publication number Publication date
WO2002008260A9 (fr) 2003-03-20
WO2002008260A3 (fr) 2002-10-17
WO2002008260A2 (fr) 2002-01-31

Similar Documents

Publication Publication Date Title
AU2001277172A1 (en) Bstp-trans protein and related reagents and methods of use thereof
WO2003059257A8 (fr) Proteines anti-angiogeniques, leurs fragments et leurs procedes d'utilisation
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001278011A1 (en) Bstp-ecg1 protein and related reagents and methods of use thereof
AU2002246808A1 (en) Human nucleic acids and polypeptides and methods of use thereof
AU2001277202A1 (en) Bstp-ras/rerg protein and related reagents and methods of use thereof
AU2001296466A1 (en) Kini-3 motor protein and methods for its use
AU2001281002A1 (en) Motor proteins and methods for their use
AU2001274566A1 (en) Novel protein and dna thereof
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2001266961A1 (en) Novel motor proteins and methods for their use
AU2001283207A1 (en) Novel motor proteins and methods for their use
AU2001292468A1 (en) Methods and means of rna analysis
AU2001284651A1 (en) Secreted proteins and methods of using same
AU2001280993A1 (en) Tissue-associated proteins and their uses
AU5634400A (en) Shank proteins and methods of use thereof
AU2001259240A1 (en) Novel stmst protein and nucleic acid mocecules and uses therefor
AU2001277200A1 (en) Bstp-cad protein and related reagents and methods of use thereof
AU2001264726A1 (en) Novel motor proteins and methods for their use
AU2001297707A1 (en) Motor proteins and methods for their use
AU2002239235A1 (en) Gpcr-like protein and nucleic acids encoding same
AU2002248697A1 (en) Novel rgs9 protein binding interactions and methods of use thereof
AU2001291195A1 (en) Nucleotide and protein sequence of helios 3 and methods of use
AU2567599A (en) Anti-ccr1 antibodies and methods of use therefor
AU2002240921A1 (en) Medane genes and proteins